Autologous tumor/dendritic cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous tumor/dendritic cell vaccine, covering 2015-12-01 to 2015-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients [Phase 2]